WorldCat Identities

Kreiter, Sebastian

Overview
Works: 6 works in 16 publications in 1 language and 296 library holdings
Roles: Editor, Contributor
Classifications: RC271.I45, 616.99406
Publication Timeline
.
Most widely held works by Sebastian Kreiter
Cancer immunotherapy meets oncology by Cedrik Michael Britten( )

10 editions published in 2014 in English and held by 289 WorldCat member libraries worldwide

This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identification of biomarkers to guide the clinical development of new approaches and to pinpoint the optimal treatment for each patient. The book acknowledges the continuing dynamic nature of the field as reflected in the development of next-generation immunotherapies that are already in clinical testing. Cancer Immunotherapy Meets Oncology is dedicated to the lifetime achievements of Christoph Huber, founder and chair of the Association for Cancer Immunotherapy (CIMT). It is also a tribute to those researchers and clinicians who are striving to develop novel diagnostics and tailored immunotherapies for the benefit of cancer patients
Cancer classification using the Immunoscore: a worldwide task force by Jerome Galon( )

2 editions published in 2012 in English and held by 3 WorldCat member libraries worldwide

Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor staging (AJCC/UICC-TNM classification) summarizes data on tumor burden (T), presence of cancer cells in draining and regional lymph nodes (N) and evidence for metastases (M). However, it is now recognized that clinical outcome can significantly vary among patients within the same stage. The current classification provides limited prognostic information, and does not predict response to therapy. Recent literature has alluded to the importance of the host immune system in controlling tumor progression. Thus, evidence supports the notion to include immunological biomarkers, implemented as a tool for the prediction of prognosis and response to therapy. Accumulating data, collected from large cohorts of human cancers, has demonstrated the impact of immune-classification, which has a prognostic value that may add to the significance of the AJCC/UICC TNM-classification. It is therefore imperative to begin to incorporate the ` Immunoscore' into traditional classification, thus providing an essential prognostic and potentially predictive tool. Introduction of this parameter as a biomarker to classify cancers, as part of routine diagnostic and prognostic assessment of tumors, will facilitate clinical decision-making including rational stratification of patient treatment. Equally, the inherent complexity of quantitative immunohistochemistry, in conjunction with protocol variation across laboratories, analysis of different immune cell types, inconsistent region selection criteria, and variable ways to quantify immune infiltration, all underline the urgent requirement to reach assay harmonization. In an effort to promote the Immunoscore in routine clinical settings, an international task force was initiated. This review represents a follow-up of the announcement of this initiative, and of the J Transl Med. editorial from January 2012. Immunophenotyping of tumors may provide crucial novel prognostic information. The results of this international validation may result in the implementation of the Immunoscore as a new component for the classification of cancer, designated TNM-I (TNM-Immune)
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma by John C Castle( )

1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide

Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice by Abderraouf Selmi( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide

Actively personalized vaccination trial for newly diagnosed glioblastoma by Norbert Hilf( )

1 edition published in 2018 in English and held by 0 WorldCat member libraries worldwide

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma by Norbert Hilf( )

1 edition published in 2019 in English and held by 0 WorldCat member libraries worldwide

 
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.49 (from 0.48 for Cancer cla ... to 1.00 for Publisher ...)

Languages
English (16)